A Mitterer
Overview
Explore the profile of A Mitterer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turecek P, Bossard M, Graninger M, Gritsch H, Hollriegl W, Kaliwoda M, et al.
Hamostaseologie
. 2012 Sep;
32 Suppl 1:S29-38.
PMID: 22961422
A longer acting recombinant FVIII is expected to serve patients' demand for a more convenient prophylactic therapy. We have developed BAX 855, a PEGylated form of Baxter's rFVIII product ADVATE™...
2.
Turecek P, Mitterer A, Matthiessen H, Gritsch H, Varadi K, Siekmann J, et al.
Hamostaseologie
. 2009 Sep;
29 Suppl 1:S32-8.
PMID: 19763356
Baxter has developed a recombinant therapy for treating von Willebrand's disease. Recombinant VWF is co-expressed with the rFVIII in CHO cells used to produce the rFVIII product Advate. This rVWF...
3.
Varadi K, Turecek P, Mitterer A, Dorner F, Schwarz H
Thromb Haemost
. 2002 Jan;
86(6):1449-58.
PMID: 11776313
Von Willebrand factor (vWF) is synthesized in endothelial cells as pre-provWF and processed intracellularly to propeptide (vWFpp) and mature vWF. Building on previous studies indicating that recombinant provWF when infused...
4.
Plaimauer B, Schlokat U, Turecek P, Mitterer A, Mundt W, Auer W, et al.
Semin Thromb Hemost
. 2001 Sep;
27(4):395-403.
PMID: 11547362
Von Willebrand factor (vWF) is a multimeric glycoprotein (GP) that attracts platelets to the site of vascular injury, mediates platelet-platelet interaction, and stabilizes factor VIII (FVIII) in the circulation. Quantitative...
5.
Turecek P, Pichler L, Auer W, Eder G, Varadi K, Mitterer A, et al.
Blood
. 1999 Sep;
94(5):1637-47.
PMID: 10477688
Although proteolytic processing of pro-von Willebrand factor (pro-vWF) resulting in free propeptide and mature vWF is known to be initiated intracellularly, vWF released from endothelial cells may contain a high...
6.
Schwarz H, Dorner F, Mitterer A, Mundt W, Schlokat U, Pichler L, et al.
Wien Klin Wochenschr
. 1999 May;
111(5):181-91.
PMID: 10226348
Dutch Kooiker dogs with hereditary von Willebrand disease (vWD) have undetectable levels of von Willebrand factor (vWF), resulting in spontaneous hemorrhage of mucosal surfaces similar to the clinical picture of...
7.
Schwarz H, Dorner F, Mitterer A, Mundt W, Schlokat U, Pichler L, et al.
Haemophilia
. 1999 Feb;
4 Suppl 3:53-62.
PMID: 10028320
Dutch Kooiker dogs with hereditary von Willebrand disease have undetectable levels of von Willebrand factor (vWF), resulting in spontaneous haemorrhage of mucosal surfaces similar to the clinical picture of von...
8.
Gerencer M, Barrett P, Kistner O, Mitterer A, Dorner F
AIDS Res Hum Retroviruses
. 1998 May;
14(7):599-605.
PMID: 9591714
Serum from rodents and felines has been found very effective in complement-dependent lysis of HIV-1, even in nonimmunized animals, but the effector molecules in animal serum and target structures on...
9.
Turecek P, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, et al.
Blood
. 1997 Nov;
90(9):3555-67.
PMID: 9345039
Hereditary von Willebrand factor (vWF ) deficiency in Dutch Kooiker dogs, which have undetectable levels of vWF, causes spontaneous hemorrhage of mucosal surfaces similar to the clinical picture of von...
10.
Schwarz H, Turecek P, Pichler L, Mitterer A, Mundt W, Dorner F, et al.
Thromb Haemost
. 1997 Jul;
78(1):571-6.
PMID: 9198218
No abstract available.